Diabetic Kidney Disease (DKD) Worsens CV Outcomes after First-Ever Major Cardiovascular Event in Type 2 Diabetes (T2D)

被引：0
|
作者：
Garofolo, Monia
Lucchesi, Daniela
Giambalvo, Massimo
Capobianco, Martina
Francesconi, Paolo
Penno, Giuseppe
Del Prato, Stefano
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-424-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of Linagliptin on Cardiovascular (CV) Risk in Type 2 Diabetes (T2D): Insights From a Pre-defined CV Meta-Analysis
    Rosenstock, Julio
    Marx, Nikolaus
    Neubacher, Dietmar
    Seck, Thomas
    Patel, Sanjay
    Woerle, Hans-Juergen
    Johansen, Odd Erik
    CIRCULATION, 2013, 128 (22)
  • [22] Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Li, Jingwei
    Neal, Bruce
    Heerspink, Hiddo L.
    Arnott, Clare
    Cannon, Christopher
    Agarwal, Rajiv
    Bakris, George
    Charytan, David M.
    de Zeeuw, Dick
    Greene, Tom
    Levin, Adeera
    Oh, Richard
    Pollock, Carol A.
    Wheeler, David C.
    Yavin, Yshai
    Zhang, Hong
    Zinman, Bernard
    Di Tanna, Gian Luca
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    Jardine, Meg
    DIABETES, 2020, 69
  • [23] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [24] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [25] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [26] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [27] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)
  • [28] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [29] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    PLOS ONE, 2014, 9 (01):
  • [30] Efficacy and Cardiovascular (CV) Safety of Linagliptin as Add-on to Insulin in Type 2 Diabetes (T2D)-A Pooled Comprehensive Posthoc Analysis
    Zinman, Bernard
    Ahren, Bo
    Neubacher, Dietmar
    Patel, Sanjay
    Johansen, Odd Erik
    Woerle, Hans J.
    DIABETES, 2014, 63 : A274 - A274
12345